After COVID-19 outbreak, pharma stocks have performed well on expectations of higher earnings. Pharma company Laurus Labs has also benefited from this momentum, surging 404% since the start of April this year. However, analysts at Anand Rathi see 29% more upside
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3gVdiuU
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3gVdiuU